Financial Performance - Revenue for Q3 2024 reached ¥134,039,056.73, an increase of 19.50% year-over-year[2] - Net profit attributable to shareholders was ¥16,328,230.89, up 147.14% compared to the same period last year[2] - Net profit excluding non-recurring items was ¥14,924,353.29, reflecting a 164.29% increase year-over-year[2] - Basic earnings per share for Q3 2024 was ¥0.2041, a rise of 147.09% from the previous year[2] - The total profit for Q3 2024 was ¥49,958,283.98, representing a 91.13% increase year-over-year[5] - Total operating revenue for Q3 2024 reached CNY 392,716,199.55, an increase of 27.4% compared to CNY 308,329,084.72 in Q3 2023[12] - Net profit attributable to shareholders of the parent company was CNY 44,083,285.92, compared to CNY 24,120,596.07 in the previous year, marking an increase of 83.0%[13] - Earnings per share for the period were CNY 0.5510, compared to CNY 0.3015 in the same quarter last year, reflecting an increase of 83.0%[13] - The company reported a total comprehensive income of CNY 44,083,285.92 for the quarter, significantly higher than CNY 24,120,596.07 from the previous year[13] Assets and Liabilities - Total assets as of September 30, 2024, amounted to ¥819,386,653.40, a 1.09% increase from the end of the previous year[2] - The total assets of the company as of September 30, 2024, are ¥819,386,653.40, compared to ¥810,539,193.07 at the beginning of the period[10] - The company's inventory as of September 30, 2024, is valued at ¥115,904,418.76, up from ¥102,511,467.92[10] - The accounts receivable amount to ¥94,083,877.98, an increase from ¥76,222,556.03[10] - The company's total current assets are ¥706,540,414.75, compared to ¥688,933,886.82 at the beginning of the period[10] - The total liabilities decreased to CNY 96,981,443.80 from CNY 122,614,406.68, a reduction of 20.8%[12] - The total liabilities include accounts payable of ¥46,271,731.79, slightly down from ¥47,452,219.26[10] Cash Flow - The company reported a net cash flow from operating activities of ¥33,779,243.40, a decrease of 33.69% compared to the previous year[6] - Cash flow from operating activities was CNY 188,056,530.00, down from CNY 197,819,281.70 in the previous year, indicating a decline of 4.4%[14] - Net cash flow from operating activities for Q3 2024 was ¥33,779,243.40, a decrease of 33.6% compared to ¥50,942,750.57 in Q3 2023[15] - Total cash inflow from investment activities was ¥36,333,228.29, up from ¥20,099,956.30 in the same period last year[15] - Cash outflow for investment activities increased significantly to ¥54,096,497.74 from ¥11,318,530.93 year-over-year[15] - Net cash flow from investment activities was -¥17,763,269.45, contrasting with a positive flow of ¥8,781,425.37 in Q3 2023[15] - Cash and cash equivalents at the end of Q3 2024 totaled ¥388,355,393.29, an increase from ¥373,626,269.33 at the end of Q3 2023[16] - The company reported a net increase in cash and cash equivalents of ¥6,833,116.05 for Q3 2024, down from ¥45,793,313.59 in Q3 2023[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 8,849[7] - The largest shareholder, Longkou Sunshine Chemical Co., Ltd., holds 42.83% of shares, totaling 34,260,000 shares[7] - The company has a significant shareholder relationship, with Li Xiumei controlling both Longkou Sunshine Chemical Co., Ltd. and Yantai Baolian Investment Center[8] - The company has not reported any changes in the top 10 shareholders participating in margin trading activities[8] Expenses - Sales expenses increased by 31.76% to ¥4,394,837.66, attributed to enhanced market expansion efforts[5] - Research and development expenses increased to CNY 17,905,504.84, up from CNY 13,790,812.48, representing a growth of 29.0%[12] - Cash paid to employees increased to ¥29,680,458.37 from ¥25,849,692.76 year-over-year[15] - Cash paid for dividends and interest in Q3 2024 was ¥9,600,000.00, down from ¥14,400,000.00 in Q3 2023[15]
联合化学(301209) - 2024 Q3 - 季度财报